Pharm Notes Exam III

Pharm Notes Exam III - Diabetes Mellitus disorder of...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
Diabetes Mellitus – disorder of carbohydrate metabolism – inability to utilize carbohydrates, accumulation of ketone bodies from the metabolism of protein and fat, high blood glucose, Type I – insulin-dependent (10%), Type II – non insulin-dependent, ketosis-resistant Desired glycemic control o Pre-meal plasma glucose: 90-130 mg/dL o Peak post-meal plasma glucose: below 180 mg/dL Powerpoint, handout Insulin – stimulates cellular uptake of glucose, amino acids, and potassium, promotes synthesis of complex organic molecules, required by all Type I diabetics and by some with Type II Diabetes Drugs Lispro (humalog) – actions similar to regular human insulin, offers insulin-using people with diabetes greater flexibility when scheduling meals, works best when taken within 15 minutes before a meal o Adverse effect – hypoglycemia (if you take it and don’t eat, or don’t eat enough) Insulin aspart – analog of human insulin with rapid onset and short duration, similar to insulin lispro, should be given immediately before meals or immediately after, use in combination Insulin glulisine – synthetic analog or natural insulin, rapid onset, short duration, must be given 15 minutes before eating or within 20 minutes after starting eating (pp) Regular insulin – 4 routes (SC, IM – rarely used), inhalation, and IV - *only insulin that can be given by IV), used for routine treatment, clear solution, two concentrations available: U100 and U500 Neutral protamine hagedorn (NPH) – delays absorption, used for daylong control – usually given 2x/day, cloudy in appearance, *only longer-acting insulin suitable to mix with regular insulin and regular insulin is always drawn up first Insulin detemir – slow onset and dose-dependent duration of action, slower onset and longer duration than NPH, clear solution Insulin glargine – used for once-daily to treat type I and II, usually taken at bedtime but can be taken in morning or after dinner, no peak in action – blood levels remain relatively constant less risk of hypo or hyperglycemia Human Insulin – genetically engineered, identical to ours, manufactured in lab (powerpoint) Total dose/day - .5-.6 units/kg/day for Type I, .2-.6 units/kg/day for type II Insulin Dosing Schedule Conventional (pp) – 2/3 15-30 min before breakfast, 1/3 15-30 minutes before dinner, need to have a snack before bedtime to avoid nocturnal hypoglycemia Intensified conventional (pp) – Tight control – most frequent complication is hypoglycemia, helps to delay onset of complications Insulin pumps – deliver basal infusion of insulin plus a bolus dose before each meal, basal infusion is usually 1 unit/hour, can be programmed to meet patient’s needs, insulin delivered through subcutaneous needle through abdomen Jet injectors – jets insulin through the skin without a needle Trying to surgically implant beta cells and having some success Drug interactions Any drug that causes hypoglycemia will intensify the hypoglycemia if on insulin (alcohol, beta blockers,
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 04/18/2008 for the course NU 204 taught by Professor Fairchild during the Spring '08 term at BC.

Page1 / 7

Pharm Notes Exam III - Diabetes Mellitus disorder of...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online